| Patents for C07C 233 - Carboxylic acid amides (28,881) |
|---|
| 04/28/2004 | CN1492852A N-phenpropylcyclopentyl-substituted glutaramide derivatives as NEP inhibitors for FSAD |
| 04/28/2004 | CN1147483C Adamantane derivatives |
| 04/28/2004 | CN1147466C Amide compounds, its prepn. method and application |
| 04/28/2004 | CN1147464C Process for producing dimethylacetamide |
| 04/27/2004 | US6727377 Asymmetric catalysis based on chiral phospholanes and hydroxyl phospholanes |
| 04/27/2004 | US6727255 Brain, nervous system and psychological disorders |
| 04/27/2004 | US6727250 Administering compounds such as trans-3-(naphth-2-yl)-but-2-enoic acid-n-(2-carboxy-phenyl)-amide or like for therapy of conditions associated with increased telomerase activity, e.g. tumour diseases |
| 04/27/2004 | US6727239 Inhibitory activity on no- synthase enzymes producing nitrogen monoxide no and/or an activity which traps the reactive oxygen species (ros) |
| 04/27/2004 | CA2093314C Compositions and polymer fabrics treated with the same |
| 04/22/2004 | WO2004013077A3 Cyclopentanone and cyclopentanone derivatives as potent activators of hsf-1 |
| 04/22/2004 | US20040077896 Compounds for the treatment of metabolic disorders |
| 04/22/2004 | US20040077728 Retiferol derivatives and their use in the treatment of skin diseases or conditions associated with photodamage |
| 04/22/2004 | US20040077725 Solid dosage form of nateglinide for oral administration |
| 04/22/2004 | US20040077694 Malonamic acids and derivatives thereof as thyroid receptor ligands |
| 04/22/2004 | US20040077693 Integrin receptor inhibitors |
| 04/22/2004 | US20040077628 Melanin-concentrating hormone antagonist |
| 04/22/2004 | US20040077618 Epilepsy, bipolar disorder, psychiatric disorders, migraine, pain, neuroprotection, movement disorders; 2-methylcyclohexanecarboxamide, or 1,1':1',1''-ter(cyclopropane)-2'-carboxamide, or (cis)(2S)-2-((((3R,5S)-3,5-dimethylcyclohexyl) carbonyl)amino)propanoic acid for example |
| 04/22/2004 | US20040077617 for example 3-methylbicyclo[4.1.0]heptane-7-carboxylic acid or N-(2-amino-2-oxoethyl)-4,7,7-trimethyltricyclo [4.1.1.02,4]octane-3-carboxamide; use treating epilepsy, bipolar disorder, migraine, neuropathic and inflammatory pain |
| 04/22/2004 | US20040077616 Spirocyclopropyl amides and acids and their therapeutic applications |
| 04/22/2004 | US20040077021 Haptens, intermediates, and immunogens that are useful in the production of antibodies specific for the methylenedioxy class of amphetamine derivatives |
| 04/21/2004 | EP1409450A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 04/21/2004 | EP1409448A1 Process for the preparation of (r)- or (s)-aminocarnitine inner salt, the salts and derivatives thereof |
| 04/21/2004 | EP1154987B1 Phenylalaninol derivatives |
| 04/21/2004 | EP0904262B1 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method |
| 04/21/2004 | CN1491208A Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical |
| 04/21/2004 | CN1491207A Acylated indanyl amines and their use as pharmaceuticals |
| 04/21/2004 | CN1491197A Tropolone derivative |
| 04/21/2004 | CN1146536C Cycloethylene derivatives |
| 04/20/2004 | USRE38506 Potent inducers of terminal differentiation and methods of use thereof |
| 04/20/2004 | US6723877 Dimethylformamide synthesis via reactive distillation of methyl formate and dimethylamine |
| 04/20/2004 | US6723868 Process for the preparation of aminoalcohol derivatives and their further conversion to (1R,4S)-4-((2-amino-6-chloro-5-formamido-4-pyrimidinyl)-amino)-2-cyclopentenyl-1-methanol |
| 04/20/2004 | US6723753 Substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 04/20/2004 | US6723749 Treating bacterial infections |
| 04/20/2004 | US6723743 Treating patient suffering from rheumatoid arthritis, psoriasis, bronchial asthma, alzheimer's disease, myocardial infarction or atherosclerosis |
| 04/15/2004 | WO2004031198A1 Enantioselective reductive methods using chiral organostannanes |
| 04/15/2004 | WO2004031161A1 Neurologically-active compounds |
| 04/15/2004 | WO2004031129A2 Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection |
| 04/15/2004 | WO2004031128A1 Improved method for the production of n-substituted amides from nitriles |
| 04/15/2004 | WO2003080554A3 Iodinated triglyceride analogs |
| 04/15/2004 | US20040073048 Antitumor agents; anticancer agents; leukemia therapy; using metal alkoxide |
| 04/15/2004 | US20040073047 Preparation of substituted isoserine esters using beta-lactams and metal or ammonium alkoxides |
| 04/15/2004 | US20040072880 Cycloalkyl inhibitors of potassium channel function |
| 04/15/2004 | US20040072878 2,3-Diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
| 04/15/2004 | US20040072854 Antiemetics; psychlogical disorders; antidepressants; anxiolytic agents; antitussive agents |
| 04/15/2004 | US20040072680 Chiral phosphorus cyclic compounds for transition metal-catalyzed asymmetric reactions |
| 04/15/2004 | US20040071640 Photostability; skin and hair protecting agents |
| 04/15/2004 | US20040071187 Compound having at least two aromatic rings substituted with at least one carboxy group |
| 04/15/2004 | CA2500935A1 Novel compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection |
| 04/14/2004 | EP1406865A2 Succinic acid derivatives |
| 04/14/2004 | EP1154985B1 Process for the industrial production of beta-hydroxyalkyl amides |
| 04/14/2004 | EP1140072B1 Compounds and methods |
| 04/14/2004 | EP0724561B1 Calcium receptor-active arylalkyl amines |
| 04/14/2004 | CN1145653C Novel catalyst composition for prodn. of polyurethane |
| 04/13/2004 | US6720453 Purity; thermodynamically stable |
| 04/13/2004 | US6720452 Adamantane derivatives |
| 04/13/2004 | US6720425 Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
| 04/13/2004 | US6720324 Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof |
| 04/13/2004 | US6720281 Chiral phosphorus ligands and the use thereof in the production of optically active products |
| 04/08/2004 | WO2004029019A2 Compounds for the treatment of alzheimer’s disease |
| 04/08/2004 | WO2004029018A1 Glycerol derivative |
| 04/08/2004 | WO2004000889A3 Polymeric photoinitiators |
| 04/08/2004 | WO2003103609A3 Novel trifluoromethylepinephrine compounds and methods of making and using thereof |
| 04/08/2004 | WO2003027068A3 Substituted amines for the treatment of neurological disorders |
| 04/08/2004 | WO2002032856A9 Insecticidal 1,8-naphthalenedicarboxamides |
| 04/08/2004 | US20040068126 Such as, hydrogenation, hydride transfer, allylic alkylation, hydrosilylation, hydroboration, hydrovinylation, hydroformylation, olefin metathesis, hydrocarboxylation, isomerization, cyclopropanation, Diels-Alder reaction, etc. |
| 04/08/2004 | US20040068013 Supplying in situ using amino acid; immobilization |
| 04/08/2004 | US20040067928 Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof |
| 04/08/2004 | US20040067927 Substituted alkyldiamines |
| 04/08/2004 | US20040067525 Method for structural analysis of organic compound |
| 04/08/2004 | CA2500109A1 Compounds for the treatment of alzheimer's disease |
| 04/07/2004 | EP1405845A1 Method for purifying n2-(1(s)-ethoxycarbonyl-3-phenylpropyl)-n6-trifluoroacetyl-l-lysine |
| 04/07/2004 | EP1404726A2 Low-molecular and high-molecular emulsifiers, particularly based on polyisobutylene, and mixtures thereof |
| 04/07/2004 | EP1404695A2 Universal supports for oligonucleotide synthesis |
| 04/07/2004 | EP1404652A1 A novel alkaloid derivative and a pharmaceutical composition containing the same |
| 04/07/2004 | EP1240132B1 Adamantane derivatives |
| 04/07/2004 | EP0910561B1 Inhibitors of oleamide hydrolase |
| 04/07/2004 | CN1487618A Molecular gel electrolyte and its prepn |
| 04/06/2004 | US6717016 Phosphine compound, transition metal complex containing the same phosphine compound as ligand and asymmetric synthesis catalyst containing the complex |
| 04/06/2004 | US6717013 Easily attained with high positional selectivity and yield; intermediates and raw materials |
| 04/06/2004 | US6716980 Cyclization and acylation of carbamate |
| 04/06/2004 | US6716882 Highly packed polycationic ammonium, sulfonium and phosphonium lipids |
| 04/06/2004 | US6716881 Carbanilides used as pesticides |
| 04/06/2004 | US6716832 Arylphenyl-substituted cyclic ketoenols |
| 04/06/2004 | CA2190992C Naphthalene derivatives |
| 04/06/2004 | CA2075926C Hydroquinone amino-acid esters, method of preparation, and pharmaceutical or cosmetic compositions containing them |
| 04/06/2004 | CA2067381C Treatment of hiv infections and compounds useful therein |
| 04/01/2004 | WO2004026815A2 Phenol derivatives and their use as rotamase inhibitors |
| 04/01/2004 | WO2004026811A2 Succinic acid semi-amides as anti-corrosives agents |
| 04/01/2004 | WO2004005478A3 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 04/01/2004 | WO2003084943A3 Terphenyl derivatives, preparation thereof, compositions containing same |
| 04/01/2004 | WO2003082777A3 Novel glucocorticoid receptor ligands |
| 04/01/2004 | US20040063980 Uniform mixing of amino acid with alkali metal compound and fatty acid halide using surfactant; circulation pipe |
| 04/01/2004 | US20040063830 Polypropylene resin compositions |
| 04/01/2004 | US20040063785 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use |
| 04/01/2004 | US20040063783 Used to treat pathologies characterized by an oxidative stress condition and a lack of availability of endothelial nitrogen monoxide, such as ischemia, restenosis, erectile dysfunction, hypoxia, transplant rejection and diabetes |
| 04/01/2004 | US20040063755 Aromatic compounds containing hydroxyalkylaminoalkylphenylaminophenyl group; useful for treating pre-term labor, neurological disorders and cardiac disorders |
| 04/01/2004 | US20040063686 Diabetes, major depression, manic depression, anxiety, schizophrenia, sleep disorders |
| 04/01/2004 | US20040063677 Omega monounsaturated fatty acid derivativatized biologically active materials; drug delivery; drug resistance; bioavail-ability |
| 04/01/2004 | US20040063671 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 04/01/2004 | US20040062773 Compositions for the delivery of antigens |